MedTrace Logo

Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)

NCT00542087 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 516

Last updated 2024-08-15

No results posted yet for this study

Summary

To compare the safety and tolerability of etoricoxib and diclofenac sodium in the treatment of osteoarthritis of the knee or hip during a six week period.

Conditions

Interventions

DRUG

MK0663, etoricoxib / Duration of Treatment: 6 Weeks

DRUG

Comparator: diclofenac sodium / Duration of Treatment: 6 Weeks

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-03-22
Primary Completion
2002-12-20
Completion
2002-12-20

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00542087 on ClinicalTrials.gov